At the end of September, the 2027 Lasker Awards were announced.

Indisputably, Tian Lu won the Lasker Award again for his great achievements in the field of epilepsy! It's just that unlike the last basic medicine award, Tian Lu won the clinical medicine award this time, and the two are very different.

Of course, this time it's exclusive!

Naturally, Tian Lu's re-award has set off another wave in China, the most lively of which is the speculation that Tian Lu won the Nobel Prize again.

This time it's not blind optimism, it's really everyone has a full reason!

If it is only based on Tian Lu's achievements in the field of epilepsy surgery or epilepsy drug treatment, it is indeed difficult to win the Nobel Prize, because after all, he has already won it once before, and it is not easy to award him the second time so early. But don't forget, in addition to the clinical achievements in epilepsy, Tian Lu's more important contribution lies in its pathogenesis, clinical grading, diagnosis and treatment standards, and so on!

For more than 20 years, the scientific research institutions under the leadership of Tian Lu have never stopped exploring epilepsy!

Until now, the Institute of Neurobiology is still tirelessly exploring the biochemical characteristics of epilepsy, and Future Biology is also developing better drugs for the treatment of epilepsy, and neurosurgery has gone further in the surgical treatment of epilepsy, and surgery combined with neural stem cell therapy has almost become a conventional means!

In 2025, after several years of evaluation and measurement, the World Federation of Epilepsy has formulated a new diagnosis and treatment guide for epilepsy with reference to the books "Epilepsy" and "Epilepsy Surgery" written by Tian Lu! And it was also at the World Epilepsy Congress this year. After Tian Lu declined the chairmanship, the World Epilepsy Federation unanimously approved the title of honorary chairman!

Such a huge achievement is enough for anyone to win the Nobel Prize!

The results of the Lasker Clinical Medicine Award undoubtedly add a heavy weight to this possibility! As a result, both at home and abroad, many people have enthusiastically discussed an issue that has not appeared in the past 100 years: Is it possible for a person to win a second Nobel Prize in his lifetime?

This undoubtedly pushed Tian Lu's prestige to another peak.

Although he was quite excited to go to the United States again, Tian Lu really wanted to meet his old friends again, but after considering various factors, he decided to give up this plan. To that end, Tian Lu made a special call to Dr. Morpheus at the San Francisco Medical Center. Ask him to help collect the prize on his behalf. And I apologized at the award ceremony.

There are a lot of domestic things, and Tian Lu really doesn't want to go out for half a month because of receiving an award.

As for finding more partners as before, or attracting more international students to return to China, etc. It's no longer necessary for Tian Lu to go out in person. I have to go out two or three times a year for Qian Lele. Including those who are already well-known in their respective fields, the leaders of the research group will naturally take on such a task。。。。。。

During the National Day. Just like last year, Tian Lu accompanied the twin daughters, who have entered the sixth grade of elementary school, for a few days.

Children are getting older day by day, and their dependence on their parents is also decreasing day by day. Tian Lu and Ye Lan also want to accompany them as much as possible while they are still willing to go out with their parents, otherwise after this year, they have their own ideas, have the ability to be independent, and even have their own boyfriends and girlfriends, I am afraid that they are not willing to go out with them even if they beg others!

Speaking of which, in terms of the growth of Tian Huan and Tian Le, Tian Lu still feels that he and Ye Lan are doing quite well.

All along, the two children have grown up healthily under everyone's care, both physically and psychologically are very healthy, and under the education of everyone, the status and wealth of their parents have not caused them any adverse effects, they are very kind children. In order to allow their children to grow up mentally healthy, Tian Lu and Ye Lan did their best to let them study in a relatively ordinary school, and they also planned to do so in junior high school in the future.

If there is anything that makes Ye Lan a little disappointed, it is that no child has the ability to inherit the geniuses of Tian Lu, and it is relatively mediocre in all aspects. Tian Lu is quite unimpressed with this, and the sentence that often hangs on his lips is that a genius like me is a busy life all his life, or just be an ordinary person and be healthy。。。。。。。

。。。。。。

Just after the National Day, another good news came from Kyoto Medicine!

"We've got the FDA's approval!"

Meng Yun's voice was full of excitement and excitement, and he shouted loudly on the phone with a slight trembling: "Antidepressants have been approved for marketing in the United States!" With this approval, I believe that by the end of the year at the latest, our new drugs will be available in various markets around the world without hindrance! ”

The FDA's strict review of new drugs is well-known all over the world, and all those who can win the U.S. market usually mean that they can pass through the world unimpeded!

"Very good!"

Tian Lu was also happy in his heart, and said with a smile: "This is called a good thing and a lot of grinding, the original plan to go public in July has been delayed to October, but for Kyoto Medicine, which has just set foot in the international market, the listing is also a huge progress!" Meng Yun, how is the hemostatic gel? Will the plan to go public by the end of the year be successfully realized? ”

"Of course there is no problem!"

Meng Yun said loudly in a very affirmative tone: "We have already said hello to the Norfi company, once the approval of both parties comes down, we will choose to go public at the same time one day, and try to expand our influence as much as possible!" You can rest assured, Kyoto Pharmaceutical's hemostatic gel is only listed in the domestic civilian market, of course, there can be no resistance! ”

"Good!"

Nodding with satisfaction, Tian Lu said with a smile: "Then your next task is to make every effort to market new drugs, and in this regard, I will form a team to conduct a global, large-sample clinical depression drug treatment cooperative study." It will take two to three years to show the excellent performance of our new drugs! Of course, in order to do this, I'm afraid that Kyoto Medicine will need a lot of money, at least $100 million a year, no problem, right? ”

"No problem! Absolutely! ”

Hearing Tian Lu say this, Meng Yun's tone changed, and he nodded desperately.

How well a new drug sells after it is marketed is ultimately in the hands of those clinicians. However, clinicians choose which drug to choose depends on whether the company's marketing channels are smooth and whether it can deliver new drugs to the hands of physicians. The second is to see how well the new drug performs. Is it convincing enough! Otherwise, there are more than a dozen antidepressant drugs on the market now, so why should people choose you Kyoto Medicine?

At this time, only rely on data to speak!

Although the number of Phase III clinical trials before marketing is also quite large. But after all, the scale is still on the small side. The persuasiveness is a little weaker. A disease with such a large number of people as depression must be studied with a large sample size, and it must be led by truly reputable physicians. The data of large-scale collaborative research organized together is convincing!

In this regard, Taro is clearly the most suitable candidate!

Not to mention that this drug was originally developed by Future Bio, let's just say that in the field of depression, Future Biotech, including Tian Lu, has published a lot of papers over the years, plus the prestige of Tian Lu itself, it is really suitable!

And more importantly, I am afraid that only Tian Lu has the ability to organize large-scale global cooperation in China!

If it is only a domestic cooperative research, Kyoto Pharmaceutical is of course able to organize itself, but in that case, it is not very convincing in developed countries such as Europe, the United States and Japan, and they generally only trust their own domestic research data, which is why it is extremely difficult for domestic new drugs to enter those markets.

And if Huaguo has a real global influence in this field, it is of course Tian Lu。。。。。。

。。。。。。

The antidepressant drug in October, the hemostatic gel in December, and within three months, the launch of a new chemical drug and a new medical consumables of Kyoto Pharmaceutical Group Company undoubtedly injected a shot of strength into the long-standing Huaguo pharmaceutical market!

These two things are really high-value blockbuster patents!

Although domestic drug research and development has improved slightly in the past decade, and new patented drugs are launched almost every year, there has never been such a heavyweight new drug!

At the end of October, Great Wall Pharmaceutical Group's smoking cessation drugs and antidote drugs were also launched at the same time!

Obviously, Great Wall Pharmaceutical Group deliberately put the two new drugs on the market together, and for this reason, they even did not hesitate to postpone the later marketing application of smoking cessation drugs, waiting for the process of detoxification drugs. Under the premise of obviously lacking sufficient strength and at the same time lacking influence, they hope to use this strong impact to increase the influence of the two new drugs!

But it turns out that their ideas are very reasonable.

In the current drug market, the drugs for smoking cessation and detoxification themselves lack representatives with sufficient effects, and they are in a state of hunger and thirst, and the performance of the two new drugs of Great Wall Pharmaceutical, not to mention, coupled with the name of the future biological product, is easy to take the lead in opening up the situation in China!

Domestic is the need for drug rehabilitation, but the market size of smoking cessation is much larger, as for foreign countries, the demand for smoking cessation drugs may not be urgent, but if you quit drugs。。。。。。

Tsk, the market is even bigger!

Everyone can expect that with just these two new drugs, Great Wall Pharmaceutical may not have to worry about it in the next ten years!

One by one, the good news made Tian Lu feel good, and in this continuous joy, time passed quietly, and soon the last day of 2027 was over。。。。。。

。。。。。。。。。。。。。。。。。。。。。

Dizzy, codeword fell asleep again.

I've been running low on energy lately, so I have to go to bed early tomorrow and have a good day's rest.

Try to still have two shifts tomorrow, but if the first one is after nine o'clock, don't wait for the second shift, I must go to bed early, hehe. (To be continued.) )